• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
    • Examining Transportation
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • America at 250
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
    • Examining Transportation
  • Newsletters
More
    Advertisement
    Home › Authors › Posts by Linda Johnson

    Linda Johnson

    Linda Johnson

    Read the latest stories and analysis from Linda Johnson.

    Pfizer seeks early approval for breast cancer drug Business

    Pfizer seeks early approval for breast cancer drug

    Linda Johnson · May 16, 2014 5:54 pm
    Merck: New drugs pending approval or in late tests Business

    Merck: New drugs pending approval or in late tests

    Linda Johnson · May 6, 2014 11:02 pm
    Bayer to buy Merck consumer business for $14.2B Business

    Bayer to buy Merck consumer business for $14.2B

    Linda Johnson · May 6, 2014 7:29 pm
    Pfizer 1Q profit drops 15 pct due to lower sales Business

    Pfizer 1Q profit drops 15 pct due to lower sales

    Linda Johnson · May 5, 2014 6:44 pm
    Advertisement
    Pfizer mulls options after AstraZeneca snubs offer Business

    Pfizer mulls options after AstraZeneca snubs offer

    Linda Johnson · May 5, 2014 5:57 pm
    J&J: Business doing well on new product approvals Business

    J&J: Business doing well on new product approvals

    Linda Johnson · April 24, 2014 8:27 pm
    Amgen misses 1Q views as higher costs cut profit Business

    Amgen misses 1Q views as higher costs cut profit

    Linda Johnson · April 22, 2014 11:13 pm
    Investor pressure pushing drugmaker M&A deals Business

    Investor pressure pushing drugmaker M&A deals

    Linda Johnson · April 22, 2014 11:03 pm
    Advertisement
    Smartphone apps remind patients to take their meds Business

    Smartphone apps remind patients to take their meds

    Linda Johnson · April 16, 2014 4:48 pm
    J&J Q1 net up 8 percent on sales jump, lower costs Business

    J&J Q1 net up 8 percent on sales jump, lower costs

    Linda Johnson · April 15, 2014 4:33 pm
    FDA OKs 1st hay fever allergy immunotherapy tablet Business

    FDA OKs 1st hay fever allergy immunotherapy tablet

    Linda Johnson · April 2, 2014 4:41 pm
    Baxter splitting into 2 separate businesses Business

    Baxter splitting into 2 separate businesses

    Linda Johnson · March 27, 2014 2:31 pm
    Advertisement
    • ‹Previous page
    • 1
    • 2
    • 3
    • 4
    • …
    • 10
    • ›Next page
    Page 2 of 10
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.